SC 13D Filing

Company

Emmaus Life Sciences, Inc.

Filed

July 28, 2006

Accession Number

0001077048-06-000377

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →